Matrix Metalloproteinase 9
"Matrix Metalloproteinase 9" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An endopeptidase that is structurally similar to MATRIX METALLOPROTEINASE 2. It degrades GELATIN types I and V; COLLAGEN TYPE IV; and COLLAGEN TYPE V.
| Descriptor ID |
D020780
|
| MeSH Number(s) |
D08.811.277.656.300.480.205.360 D08.811.277.656.300.480.252.445 D08.811.277.656.300.480.525.700.350 D08.811.277.656.675.374.205.360 D08.811.277.656.675.374.252.445 D08.811.277.656.675.374.525.700.350 D12.644.276.848.350 D12.776.467.836.350
|
| Concept/Terms |
Matrix Metalloproteinase 9- Matrix Metalloproteinase 9
- Metalloproteinase 9, Matrix
- 92-kDa Type IV Collagenase
- 92 kDa Type IV Collagenase
- Matrix Metalloproteinase-9
- MMP9 Metalloproteinase
- Metalloproteinase, MMP9
- MMP-9 Metalloproteinase
- MMP 9 Metalloproteinase
- Metalloproteinase, MMP-9
- 92-kDa Gelatinase
- 92 kDa Gelatinase
- Gelatinase B
|
Below are MeSH descriptors whose meaning is more general than "Matrix Metalloproteinase 9".
Below are MeSH descriptors whose meaning is more specific than "Matrix Metalloproteinase 9".
This graph shows the total number of publications written about "Matrix Metalloproteinase 9" by people in this website by year, and whether "Matrix Metalloproteinase 9" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 0 | 1 | 1 |
| 1995 | 0 | 1 | 1 |
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 3 | 3 |
| 1998 | 0 | 2 | 2 |
| 2000 | 0 | 1 | 1 |
| 2001 | 2 | 2 | 4 |
| 2002 | 0 | 2 | 2 |
| 2003 | 1 | 1 | 2 |
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 2 | 2 |
| 2006 | 4 | 2 | 6 |
| 2007 | 3 | 0 | 3 |
| 2008 | 0 | 3 | 3 |
| 2009 | 0 | 3 | 3 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 2 | 2 |
| 2012 | 1 | 4 | 5 |
| 2013 | 2 | 1 | 3 |
| 2014 | 1 | 1 | 2 |
| 2015 | 2 | 0 | 2 |
| 2017 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 1 | 2 |
| 2021 | 1 | 1 | 2 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Matrix Metalloproteinase 9" by people in Profiles.
-
A spatially anchored transcriptomic atlas of the human kidney papilla identifies significant immune injury in patients with stone disease. Nat Commun. 2023 07 19; 14(1):4140.
-
Macrophage Depletion Reduces Disease Pathology in Factor H-Dependent Immune Complex-Mediated Glomerulonephritis. J Immunol Res. 2022; 2022:1737419.
-
Myeloid-Derived Suppressor Cells Mediate T Cell Dysfunction in Nonhuman Primate TB Granulomas. mBio. 2021 12 21; 12(6):e0318921.
-
Tubular lysosomes harbor active ion gradients and poise macrophages for phagocytosis. Proc Natl Acad Sci U S A. 2021 10 12; 118(41).
-
Involvement of the Commensal Organism Bacillus subtilis in the Pathogenesis of Anastomotic Leak. Surg Infect (Larchmt). 2020 Dec; 21(10):865-870.
-
An in vitro tissue model for screening sustained release of phosphate-based therapeutic attenuation of pathogen-induced proteolytic matrix degradation. J Mater Chem B. 2020 03 25; 8(12):2454-2465.
-
Bone Morphogenetic Protein-9-Stimulated Adipocyte-Derived Mesenchymal Progenitors Entrapped in a Thermoresponsive Nanocomposite Scaffold Facilitate Cranial Defect Repair. J Craniofac Surg. 2019 Sep; 30(6):1915-1919.
-
Astrocytes promote progression of breast cancer metastases to the brain via a KISS1-mediated autophagy. Autophagy. 2017; 13(11):1905-1923.
-
Randomised clinical trial: a phase 1, dose-ranging study of the anti-matrix metalloproteinase-9 monoclonal antibody GS-5745 versus placebo for ulcerative colitis. Aliment Pharmacol Ther. 2016 07; 44(2):157-69.
-
Matrix Metalloproteinase-9 Mediates RSV Infection in Vitro and in Vivo. Viruses. 2015 Jul 30; 7(8):4230-53.